Stratos Wealth Advisors »

Candel Therapeutics shares owned by Stratos Wealth Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Stratos Wealth Advisors from 13F filings

Historical chart of Stratos Wealth Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Stratos Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Stratos Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $117k 23k 5.10
2025-06-30 $116k 23k 5.06
2025-03-31 $130k 23k 5.65

More positions owned by Stratos Wealth Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfli Intrmdit (SPTI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for Stratos Wealth Advisors

Top funds holding Candel Therapeutics

FMR
Acorn Capital Advisors
BlackRock
Vanguard Group
Portolan Capital Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Citadel Advisors
Sands Capital Ventures
Susquehanna International
Northern Trust
Nuveen
Tanager Wealth Management
Wellington Management Company

View all funds holding Candel Therapeutics